Can you provide the last earnings date for NOVABRIDGE BIOSCIENCES?
NOVABRIDGE BIOSCIENCES (NBP) last reported earnings on 4/7/2026.
NASDAQ:NBP • US44975P1030
Past quarterly earnings results for NOVABRIDGE BIOSCIENCES (NBP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.29 | -0.05 | -446.91% | -262.50% | - | - | ||
| Q3 2025 | -0.03 | -0.05 | 37.47% | 88.00% | - | - | ||
| Q2 2025 | -0.07 | -0.04 | -63.37% | 85.65% | - | - | ||
| Q1 2025 | -0.03 | -0.07 | 54.30% | 85.71% | - | - | ||
| Q4 2024 | -0.08 | -0.06 | -39.77% | 86.84% | - | -100.00% | ||
| Q3 2024 | -0.25 | -0.23 | -6.65% | 3.40% | - | - | ||
| Q2 2024 | -0.46 | -1.31 | 65.02% | 42.48% | - | -100.00% | ||
| Q1 2024 | -0.21 | -0.22 | 5.31% | 25.59% | - | - | ||
| Q4 2023 | -0.61 | - | 24.02% | 27.644M | 1.123M | 2,361.62% | 110.11% | |
| Q3 2023 | -0.26 | - | 47.49% | - | - | |||
| Q2 2023 | -0.80 | - | - | 19.655M | 2.525M | 678.42% | -62.10% | |
| Q1 2023 | -0.28 | - | - | - | - | |||
| Q4 2022 | -0.80 | - | -129.58% | -273.421M | 17.675M | -1,646.94% | -489.21% | |
| Q3 2022 | -0.49 | - | -2.10% | - | - | |||
| Q2 2022 | - | - | 51.858M | - | 191.75% | |||
| Q4 2021 | -0.35 | - | -137.81% | 70.251M | 111.1M | -36.77% | -95.45% | |
| Q3 2021 | -0.48 | - | -67.68% | - | - | |||
| Q2 2021 | -1.08 | - | -101.64% | 17.775M | - | - | ||
| Q1 2021 | -0.37 | - | - | - | - | |||
| Q4 2020 | 0.92 | - | - | 1.543B | 152.54M | 911.34% | - | |
| Q3 2020 | -0.29 | - | - | - | - | |||
| Q2 2020 | -0.54 | - | - | - | - |
Notes
NOVABRIDGE BIOSCIENCES (NBP) last reported earnings on 4/7/2026.
NOVABRIDGE BIOSCIENCES (NBP) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, NOVABRIDGE BIOSCIENCES (NBP) has beaten EPS estimates in 2 out of 4 releases.